Skip to main content
Erschienen in: Journal of Neuro-Oncology 2/2024

11.01.2024 | Research

Risk factors for glioblastoma in adults in Japan: an exploratory cohort study based on the Shizuoka Kokuho Database, the Shizuoka study

verfasst von: Akinori Miyakoshi, Nanako Ubukata, Hiromu Miyake, Aya Shoji-Asahina, Hisashi Dote, Emi Ohata, Daito Funaki, Yoshikazu Ichikawa, Yutaro Imaichi, Michiko Oshima, Philip Hawke, Eiji Nakatani

Erschienen in: Journal of Neuro-Oncology | Ausgabe 2/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To elucidate the risk factors associated with the onset of glioblastoma (GBM) utilizing a comprehensive administrative claims database from a major governmental district in Japan.

Methods

Using the Shizuoka Kokuho Database (SKDB) for the period from April 2012 to September 2021, we conducted a retrospective analysis of 1,465,353 participants, identifying GBM cases using specific Japanese disease codes in conjunction with associated treatments. Risk factors were assessed using both univariable and multivariable Cox proportional hazards models.

Results

Within the cohort, 182 participants (0.012%) received a GBM diagnosis during the study period, resulting in an incidence rate of 2.1 per 100,000 person-years. The multivariable analysis revealed that older age, male sex, and peripheral vascular disease (PVD) significantly influenced the risk of GBM onset. No clear link was found between allergic conditions and GBM risk, in contrast to some previous research.

Conclusion

Employing a robust health insurance database, this study revealed significant associations between GBM and factors such as age, male sex, and PVD within the Japanese population. It provides key insights into GBM epidemiology and underscores the potential of health insurance databases for large-scale oncological research.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Ostrom QT, Price M, Neff C et al (2023) CBTRUS Statistical Report: primary brain and other Central Nervous System tumors diagnosed in the United States in 2016–2020. Neuro Oncol 25:iv1–iv99CrossRefPubMed Ostrom QT, Price M, Neff C et al (2023) CBTRUS Statistical Report: primary brain and other Central Nervous System tumors diagnosed in the United States in 2016–2020. Neuro Oncol 25:iv1–iv99CrossRefPubMed
2.
Zurück zum Zitat (2017) Brain Tumor Registry of Japan (2005–2008). Neurol Med Chir 57:9–102 (2017) Brain Tumor Registry of Japan (2005–2008). Neurol Med Chir 57:9–102
3.
Zurück zum Zitat Omuro A, DeAngelis LM (2013) Glioblastoma and other malignant gliomas: a clinical review. JAMA 310:1842–1850CrossRefPubMed Omuro A, DeAngelis LM (2013) Glioblastoma and other malignant gliomas: a clinical review. JAMA 310:1842–1850CrossRefPubMed
4.
Zurück zum Zitat Bondy ML, Scheurer ME, Malmer B et al (2008) Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer 113:1953–1968CrossRefPubMed Bondy ML, Scheurer ME, Malmer B et al (2008) Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer 113:1953–1968CrossRefPubMed
5.
Zurück zum Zitat Linos E, Raine T, Alonso A, Michaud D (2007) Atopy and risk of brain tumors: a meta-analysis. J Natl Cancer Inst 99:1544–1550CrossRefPubMed Linos E, Raine T, Alonso A, Michaud D (2007) Atopy and risk of brain tumors: a meta-analysis. J Natl Cancer Inst 99:1544–1550CrossRefPubMed
6.
Zurück zum Zitat Amirian ES, Zhou R, Wrensch MR et al (2016) Approaching a scientific Consensus on the Association between allergies and Glioma Risk: a report from the Glioma International Case-Control Study. Cancer Epidemiol Biomarkers Prev 25:282–290CrossRefPubMedPubMedCentral Amirian ES, Zhou R, Wrensch MR et al (2016) Approaching a scientific Consensus on the Association between allergies and Glioma Risk: a report from the Glioma International Case-Control Study. Cancer Epidemiol Biomarkers Prev 25:282–290CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Krishnamachari B, Il’yasova D, Scheurer ME et al (2015) A pooled multisite analysis of the effects of atopic medical conditions in glioma risk in different ethnic groups. Ann Epidemiol 25:270–274CrossRefPubMedPubMedCentral Krishnamachari B, Il’yasova D, Scheurer ME et al (2015) A pooled multisite analysis of the effects of atopic medical conditions in glioma risk in different ethnic groups. Ann Epidemiol 25:270–274CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Nelson JS, Burchfiel CM, Fekedulegn D, Andrew ME (2012) Potential risk factors for incident glioblastoma multiforme: the Honolulu Heart Program and Honolulu-Asia Aging Study. J Neurooncol 109:315–321CrossRefPubMedPubMedCentral Nelson JS, Burchfiel CM, Fekedulegn D, Andrew ME (2012) Potential risk factors for incident glioblastoma multiforme: the Honolulu Heart Program and Honolulu-Asia Aging Study. J Neurooncol 109:315–321CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Porter AB, Lachance DH, Johnson DR (2015) Socioeconomic status and glioblastoma risk: a population-based analysis. Cancer Causes Control 26:179–185CrossRefPubMed Porter AB, Lachance DH, Johnson DR (2015) Socioeconomic status and glioblastoma risk: a population-based analysis. Cancer Causes Control 26:179–185CrossRefPubMed
10.
Zurück zum Zitat Simińska D, Korbecki J, Kojder K et al (2021) Epidemiology of anthropometric factors in Glioblastoma Multiforme—Literature Review. Brain Sci 11:116CrossRefPubMedPubMedCentral Simińska D, Korbecki J, Kojder K et al (2021) Epidemiology of anthropometric factors in Glioblastoma Multiforme—Literature Review. Brain Sci 11:116CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Sergentanis TN, Tsivgoulis G, Perlepe C et al (2015) Obesity and risk for Brain/CNS Tumors, gliomas and meningiomas: a Meta-analysis. PLoS ONE 10:e0136974CrossRefPubMedPubMedCentral Sergentanis TN, Tsivgoulis G, Perlepe C et al (2015) Obesity and risk for Brain/CNS Tumors, gliomas and meningiomas: a Meta-analysis. PLoS ONE 10:e0136974CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Nishimura S, Kumamaru H, Shoji S et al (2022) Assessment of coding-based frailty algorithms for long-term outcome prediction among older people in community settings: a cohort study from the Shizuoka Kokuho Database. https://doi.org/10.1093/ageing/afac009. Age Ageing 51. Nishimura S, Kumamaru H, Shoji S et al (2022) Assessment of coding-based frailty algorithms for long-term outcome prediction among older people in community settings: a cohort study from the Shizuoka Kokuho Database. https://​doi.​org/​10.​1093/​ageing/​afac009. Age Ageing 51.
14.
Zurück zum Zitat Ubukata N, Nakatani E, Hashizume H et al (2023) Risk factors and drugs that trigger the onset of Stevens-Johnson syndrome and toxic epidermal necrolysis: a population-based cohort study using the Shizuoka Kokuho database. JAAD Int 11:24–32CrossRefPubMed Ubukata N, Nakatani E, Hashizume H et al (2023) Risk factors and drugs that trigger the onset of Stevens-Johnson syndrome and toxic epidermal necrolysis: a population-based cohort study using the Shizuoka Kokuho database. JAAD Int 11:24–32CrossRefPubMed
16.
Zurück zum Zitat Benchimol EI, Smeeth L, Guttmann A et al (2015) The REporting of studies conducted using Observational routinely-collected health data (RECORD) statement. PLoS Med 12:e1001885CrossRefPubMedPubMedCentral Benchimol EI, Smeeth L, Guttmann A et al (2015) The REporting of studies conducted using Observational routinely-collected health data (RECORD) statement. PLoS Med 12:e1001885CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Ohgaki H, Kleihues P (2013) The definition of primary and secondary glioblastoma. Clin Cancer Res 19:764–772CrossRefPubMed Ohgaki H, Kleihues P (2013) The definition of primary and secondary glioblastoma. Clin Cancer Res 19:764–772CrossRefPubMed
18.
Zurück zum Zitat Quan H, Sundararajan V, Halfon P et al (2005) Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 43:1130–1139CrossRefPubMed Quan H, Sundararajan V, Halfon P et al (2005) Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 43:1130–1139CrossRefPubMed
19.
Zurück zum Zitat Elixhauser A, Steiner C, Harris DR, Coffey RM (1998) Comorbidity measures for use with administrative data. Med Care 36:8–27CrossRefPubMed Elixhauser A, Steiner C, Harris DR, Coffey RM (1998) Comorbidity measures for use with administrative data. Med Care 36:8–27CrossRefPubMed
21.
Zurück zum Zitat Chen B, Chen C, Zhang Y, Xu J (2021) Recent incidence trend of elderly patients with Glioblastoma in the United States, 2000–2017. BMC Cancer 21:54CrossRefPubMedPubMedCentral Chen B, Chen C, Zhang Y, Xu J (2021) Recent incidence trend of elderly patients with Glioblastoma in the United States, 2000–2017. BMC Cancer 21:54CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Kim M, Ladomersky E, Mozny A et al (2021) Glioblastoma as an age-related neurological disorder in adults. Neurooncol Adv 3:vdab125PubMedPubMedCentral Kim M, Ladomersky E, Mozny A et al (2021) Glioblastoma as an age-related neurological disorder in adults. Neurooncol Adv 3:vdab125PubMedPubMedCentral
23.
Zurück zum Zitat Morley RL, Sharma A, Horsch AD, Hinchliffe RJ (2018) Peripheral artery disease. BMJ 360:j5842CrossRefPubMed Morley RL, Sharma A, Horsch AD, Hinchliffe RJ (2018) Peripheral artery disease. BMJ 360:j5842CrossRefPubMed
24.
Zurück zum Zitat Rantner B, Kollerits B, Pohlhammer J et al (2017) The fate of patients with intermittent claudication in the 21st century revisited - results from the CAVASIC Study. Sci Rep 8:45833ADSCrossRefPubMed Rantner B, Kollerits B, Pohlhammer J et al (2017) The fate of patients with intermittent claudication in the 21st century revisited - results from the CAVASIC Study. Sci Rep 8:45833ADSCrossRefPubMed
25.
Zurück zum Zitat Taute B-M, Thommes S, Taute R, Podhaisky H (2011) The possible risk of cancer in claudicants. Angiology 62:579–584CrossRefPubMed Taute B-M, Thommes S, Taute R, Podhaisky H (2011) The possible risk of cancer in claudicants. Angiology 62:579–584CrossRefPubMed
26.
Zurück zum Zitat Onega T, Baron JA, Johnsen SP et al (2015) Cancer risk and subsequent survival after hospitalization for intermittent claudication. Cancer Epidemiol Biomarkers Prev 24:744–748CrossRefPubMed Onega T, Baron JA, Johnsen SP et al (2015) Cancer risk and subsequent survival after hospitalization for intermittent claudication. Cancer Epidemiol Biomarkers Prev 24:744–748CrossRefPubMed
27.
Zurück zum Zitat Kaschwich M, Peters F, Hischke S et al (2020) Long-term incidence of cancer after index treatment for symptomatic peripheral arterial disease - a health insurance claims data analysis. Vasa 49:493–499CrossRefPubMed Kaschwich M, Peters F, Hischke S et al (2020) Long-term incidence of cancer after index treatment for symptomatic peripheral arterial disease - a health insurance claims data analysis. Vasa 49:493–499CrossRefPubMed
28.
Zurück zum Zitat Bintein F, Yannoutsos A, Chatellier G et al (2021) Patients with atherosclerotic peripheral arterial disease have a high risk of lung cancer: systematic review and meta-analysis of literature. J Med Vasc 46:53–65PubMed Bintein F, Yannoutsos A, Chatellier G et al (2021) Patients with atherosclerotic peripheral arterial disease have a high risk of lung cancer: systematic review and meta-analysis of literature. J Med Vasc 46:53–65PubMed
29.
Zurück zum Zitat Schwartzbaum J, Jonsson F, Ahlbom A et al (2003) Cohort studies of association between self-reported allergic conditions, immune-related diagnoses and glioma and meningioma risk. Int J Cancer 106:423–428CrossRefPubMed Schwartzbaum J, Jonsson F, Ahlbom A et al (2003) Cohort studies of association between self-reported allergic conditions, immune-related diagnoses and glioma and meningioma risk. Int J Cancer 106:423–428CrossRefPubMed
Metadaten
Titel
Risk factors for glioblastoma in adults in Japan: an exploratory cohort study based on the Shizuoka Kokuho Database, the Shizuoka study
verfasst von
Akinori Miyakoshi
Nanako Ubukata
Hiromu Miyake
Aya Shoji-Asahina
Hisashi Dote
Emi Ohata
Daito Funaki
Yoshikazu Ichikawa
Yutaro Imaichi
Michiko Oshima
Philip Hawke
Eiji Nakatani
Publikationsdatum
11.01.2024
Verlag
Springer US
Erschienen in
Journal of Neuro-Oncology / Ausgabe 2/2024
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-024-04566-w

Weitere Artikel der Ausgabe 2/2024

Journal of Neuro-Oncology 2/2024 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.